High-Ownership Growth Stocks With Insiders Holding Up To 33%

In a week marked by cautious Federal Reserve commentary and political uncertainty, global markets experienced significant fluctuations with U.S. stocks declining broadly before a late-week rally. Amidst these turbulent conditions, investors are increasingly focusing on growth companies where high insider ownership can signal confidence in the company's prospects and align management's interests with those of shareholders. In the current market landscape, identifying stocks with substantial insider ownership may offer a sense of stability and potential for growth, as insiders' vested interest often indicates their belief in the company's long-term success.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
SKS Technologies Group (ASX:SKS)	29.7%	24.8%
People & Technology (KOSDAQ:A137400)	16.4%	37.3%
Archean Chemical Industries (NSEI:ACI)	22.9%	41.3%
Kirloskar Pneumatic (BSE:505283)	30.3%	26.3%
Laopu Gold (SEHK:6181)	36.4%	34.2%
Plenti Group (ASX:PLT)	12.8%	120.1%
Brightstar Resources (ASX:BTR)	16.2%	84.5%
Credo Technology Group Holding (NasdaqGS:CRDO)	13.4%	66.3%
HANA Micron (KOSDAQ:A067310)	18.5%	110.9%
Findi (ASX:FND)	34.8%	112.9%

Click here to see the full list of 1515 stocks from our Fast Growing Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

Seegene (KOSDAQ:A096530)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Seegene, Inc. is a global manufacturer and seller of molecular diagnostics products, with a market cap of ₩1.08 trillion.

Operations: Seegene generates its revenue from the global sale of molecular diagnostics products.

Insider Ownership: 33.1%

Seegene's earnings are forecast to grow significantly, outpacing the Korean market with an expected 35.2% annual increase. Recent strategic alliances, such as the partnership with Werfen to form a NewCo in Spain, aim to expand Seegene's diagnostic technologies globally. Despite these growth prospects, challenges include a dividend not well covered by earnings and low future return on equity forecasts. Recent financials show improved profitability with KRW 23.64 billion net income for nine months ending September 2024.

• Click here to discover the nuances of Seegene with our detailed analytical future growth report.
• Upon reviewing our latest valuation report, Seegene's share price might be too optimistic.

Adicon Holdings (SEHK:9860)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Adicon Holdings Limited operates medical laboratories in the People’s Republic of China with a market cap of HK$4.59 billion.

Operations: The company generates revenue of CN¥3.12 billion from its Healthcare Facilities & Services segment.

Insider Ownership: 22.4%

Adicon Holdings is positioned for significant earnings growth, projected at 20.17% annually, surpassing the Hong Kong market's 11.6%. However, its forecasted Return on Equity of 15.1% in three years may be a concern for some investors. Revenue is expected to grow at 9% per year, outpacing the local market but below high-growth benchmarks. Analysts see potential with a consensus price increase of 61.2%, though recent insider trading data is unavailable.

• Delve into the full analysis future growth report here for a deeper understanding of Adicon Holdings.
• Our expertly prepared valuation report Adicon Holdings implies its share price may be too high.

Stemmer Imaging (XTRA:S9I)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Stemmer Imaging AG offers machine vision technology for various industrial and non-industrial applications globally, with a market cap of €360.10 million.

Operations: The company generates revenue of €113.27 million from its machine vision technology segment, serving both industrial and non-industrial sectors worldwide.

Insider Ownership: 15.4%

Stemmer Imaging is poised for substantial growth, with earnings forecasted to rise 37.2% annually, outpacing the German market's 20.6%. Despite a recent net loss of €1.17 million in Q3 2024 compared to a profit last year, its revenue growth of 11.3% per year remains promising relative to the local market. The recent acquisition by MiddleGround Management securing an 83.54% stake underscores significant insider confidence and potential strategic realignment opportunities.

• Dive into the specifics of Stemmer Imaging here with our thorough growth forecast report.
• According our valuation report, there's an indication that Stemmer Imaging's share price might be on the expensive side.

Summing It All Up

• Navigate through the entire inventory of 1515 Fast Growing Companies With High Insider Ownership here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com